Novo Nordisk Canada considers competing with generics through renamed lower-price Ozempic

Health Canada is currently considering nine submissions from other drug companies to make generic semaglutide.

Cheaper obesity medications could come to Canada this summer, as Health Canada reviews generics

In Canada, the patent for some semaglutide drugs has expired, paving the way for the country to become the first to offer ...

Corcept Therapeutics: Despite FDA Blind Side, Relacorilant Remains A Viable Drug

Corcept Therapeutics (CORT) leverages Korlym’s commercial success in hypercortisolism, generating $559.3M in nine-month 2025 ...
The Canadian Press on MSN

Companies can make generic Ozempic as of next week, but don't expect to get it soon

Drug companies in Canada are allowed to make lower priced generic versions of the blockbuster drug Ozempic as of next week, ...
The National Law Review

Coffee, Tea, or Doctrine of Foreign Equivalents?

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation and ...
IEEE

An Enhanced Equivalent Circuit Model With Real-Time Parameter Identification for Battery State-of-Charge Estimation

Abstract: This article introduces an efficient modeling approach based on the Wiener structure to reinforce the capacity of classical equivalent circuit models (ECMs) in capturing the nonlinearities ...
Multiple Sclerosis News Today

FDA gives tentative approval to generic Siponimod tablets for MS

The FDA has tentatively approved generic siponimod for relapsing forms of multiple sclerosis. It treats clinically isolated syndrome, relapsing-remitting MS, and active secondary progressive MS. This ...